Treatment with PKI-587 and imatinib mesylate effectively inhibited the phosphorylation of Akt and mTOR in PDX tumours, and imatinib inhibited PDGFRB phosphorylation (Fig. 5h, i). This evidence concerns the gene PDGFRB and neoplasm.